4.7 Article

Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species

Journal

BIOMOLECULES
Volume 11, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/biom11071037

Keywords

kinases; bioinformatics; drug discovery; molecular docking; PI3K; AKT pathway

Funding

  1. Direccion General de Investigaciones of Universidad Santiago de Cali [01-2021]
  2. Minciencias
  3. Max Planck Society, Germany
  4. University of Antioquia
  5. Ruta N, Colombia

Ask authors/readers for more resources

The study explores the feasibility of blocking the PI3K/AKT pathway in Leishmania, identifies five protein kinases in different Leishmania species, and suggests starting point scaffolds for inhibitor design.
Leishmaniasis is a public health disease that requires the development of more effective treatments and the identification of novel molecular targets. Since blocking the PI3K/AKT pathway has been successfully studied as an effective anticancer strategy for decades, we examined whether the same approach would also be feasible in Leishmania due to their high amount and diverse set of annotated proteins. Here, we used a best reciprocal hits protocol to identify potential protein kinase homologues in an annotated human PI3K/AKT pathway. We calculated their ligandibility based on available bioactivity data of the reported homologues and modelled their 3D structures to estimate the druggability of their binding pockets. The models were used to run a virtual screening method with molecular docking. We found and studied five protein kinases in five different Leishmania species, which are AKT, CDK, AMPK, mTOR and GSK3 homologues from the studied pathways. The compounds found for different enzymes and species were analysed and suggested as starting point scaffolds for the design of inhibitors. We studied the kinases' participation in protein-protein interaction networks, and the potential deleterious effects, if inhibited, were supported with the literature. In the case of Leishmania GSK3, an inhibitor of its human counterpart, prioritized by our method, was validated in vitro to test its anti-Leishmania activity and indirectly infer the presence of the enzyme in the parasite. The analysis contributes to improving the knowledge about the presence of similar signalling pathways in Leishmania, as well as the discovery of compounds acting against any of these kinases as potential molecular targets in the parasite.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available